TRCT
OCS icon

Tower Research Capital (TRC)’s Oculis Holding OCS Stock Holding History

Tower Research Capital (TRC)’s Portfolio OCS Stock Details OCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26
Closed -$495 – 5484
2025
Q1 		$495 Buy
+26
New +$533 ﹤0.01% 4883
2023
Q4 		– Sell
-204
Closed -$2.24K – 6098
2023
Q3 		$2.24K Buy
+204
New +$2.56K ﹤0.01% 5184

Other funds holding OCS

PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tower Research Capital (TRC)'s OCS Position: Q2 2025 in Review

Tower Research Capital (TRC) sold out of Oculis Holding (OCS) in Q2 2025, closing a stake of 26 shares — an estimated $495 sold.

Tower Research Capital (TRC) first reported a position in OCS in Q3 2023 and held it in 2 quarters. The position peaked at $2.24K in Q3 2023. 23 funds tracked by Wall St. Rank hold OCS as of Q2 2025.

  • Tower Research Capital (TRC) reported no remaining Oculis Holding position as of Q2 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 26 Oculis Holding shares in Q2 2025, an estimated $495.
  • Tower Research Capital (TRC) first reported a position in Oculis Holding in Q3 2023 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Oculis Holding position peaked at $2.24K in Q3 2023.
  • 23 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.